Topical ocular chloramphenicol: clinical pharmacology and toxicity in optometric practice
Kairys, D.; Smith, M.B.
Journal of the American Optometric Association 61(1): 14-17
1990
ISSN/ISBN: 0003-0244 PMID: 2319086 Document Number: 367258
Document emailed within 1 workday
Related Documents
Maren, T.H.; Bar-Ilan, A.; Caster, K.C.; Katritzky, A.R. 1987: Ocular pharmacology of methazolamide analogs: distribution in the eye and effects on pressure after topical application Journal of Pharmacology and Experimental Therapeutics 241(1): 56-63Bailey, J.H. 1975: American Optometric Association Delphi Program. Future of optometric practice Journal of the American Optometric Association 46(5): 547-552
Amos, J.F.; Miller, S.C. 1995: The development and significance of optometric clinical practice guidelines Journal of the American Optometric Association 66(8): 464-465
Chang, F.W. 1977: Pharmacology of mydriasis for modern optometric procedures Journal of the American Optometric Association 48(11): 1365-1368
Miller, A.A.; Schmidt, C.G. 1987: Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin Cancer Research 47(5): 1461-1465
Morgan, J.P.; Solomon, J.L. 1978: Phencyclidine. Clinical pharmacology and toxicity New York State Journal of Medicine 78(13): 2035-2038
Harper, J.C. 2010: Benzoyl peroxide development, pharmacology, formulation and clinical uses in topical fixed-combinations Journal of Drugs in Dermatology: Jdd 9(5): 482-487
Gjerden, P.; Slørdal, L. 1998: Clinical pharmacology of anticholinergic antiparkinson agents. a review with emphasis on acute toxicity Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(1): 53-55
Vogelson, C.T.; Abelson, M.B.; Pasquine, T.; Stephens, D.M.; Gamache, D.A.; Gross, R.D.; Robertson, S.M.; Yanni, J.M. 2004: Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration Allergy and Asthma Proceedings 25(1): 69-75
Rivera, M.J.; Cabello, A.; Gomez-Lus, R. 1989: Chloramphenicol resistance in clinical isolates of enterobacteria: characterization of chloramphenicol acetyltransferases Journal of ChemoTherapy 1(4 Suppl): 309-310
Calderón, E.; Gilman, R.H.; Snyder, M.J.; Vázquez, V.; Barreto, D.G.; Legorreta, J.; Rodríguez, R.; Martínez, E.; Hornick, R.B.; Woodward, T.E. 1974: A controlled clinical trial of chloramphenicol in chloramphenicol-resistant typhoid fever Revista Latinoamericana de Microbiologia 16(3): 131-136
Soto, J.; Sacristán, J.A.; Alsar, M.J. 1992: The use of topical chloramphenicol Revista Clinica Espanola 191(6): 336-337
Tassin, J.P. 1996: Deficit schizophrenia: from pharmacology to clinical practice L'Encephale 22(Special Issue 2): 9-12
López Lázaro, L. 1998: The situation of clinical pharmacology in general practice in Spain Methods and Findings in Experimental and Clinical Pharmacology 20 Suppl A: 37-38
Young, G. 1989: Research in optometric practice Journal of the American Optometric Association 60(10): 724
Watson, A.D. 1977: Chloramphenicol toxicity in dogs Research in Veterinary Science 23(1): 66-69
Erde, E.; Abplanalp, P. 1984: Ethical issues in optometric practice Journal of the American Optometric Association 55(7): 533-536
Macgregor, A.G. 1970: Personal point of view--clinical pharmacology and modern medical practice Health Bulletin 28(3): 69-71
Sullins, W.D. 1992: What will the scope of optometric practice be in the year 2000? Journal of the American Optometric Association 63(11): 766-767
Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137